PACDB provides the information on pathogens (e.g. bacteria, fungus, toxin and virus) adhering to carbohydrates expressed on the cell surface of host animals or plants.
Database | Last Updated |
---|---|
Pathogen Adherence to Carbohydrate Database (PACDB) | June 1, 2016 |
Species | Pathogen Adherence Molecule | Ligand Name | Ligand Feature | Target Source | Glycan Sequence ▲ | Binding | PubMed ID |
---|---|---|---|---|---|---|---|
Unknown
|
B6 type 2 glycosphingolipid (B6-2)
|
Oligoglycosylceramides
|
Human erythrocytes
|
Gal(a1-3)[Fuc(a1-2)]Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)Glc(b1-1)Cer
|
Not Binding
|
||
B subunit
|
B6 type 2 glycosphingolipid (B6-2)
|
Oligoglycosylceramides
|
Human erythrocytes
|
Gal(a1-3)[Fuc(a1-2)]Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)Glc(b1-1)Cer
|
Not Binding
|
||
Unknown
|
unnamed ligand
|
Oligoglycosylceramides
|
Various sources
|
Gal(a1-3)[Fuc(a1-2)]Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-3)Gal(b1-4)Glc(b1-1)Cer
|
Not Binding
|
||
Unknown
|
unnamed ligand
|
Oligoglycosylceramides
|
Various sources
|
Gal(a1-3)[Fuc(a1-2)]Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-3)Gal(b1-4)Glc(b1-1)Cer
|
Not Binding
|
||
PapG
|
alpha-D-galactopyranosyl-(1-4)-beta-D-galactopyranose
|
Disaccharides
|
Uroepithelial cells
|
Gal(a1-4)Gal
|
Binding
|
||
P-fimbriae
|
Gal alpha 1-4 Gal-containing glicolipids
|
Glycolipids
|
Pyelonephritis patients
|
Gal(a1-4)Gal
|
Binding
|
||
PapG
|
Gal alpha 1-4 Gal-containing glicolipids
|
Glycolipids
|
Pyelonephritis patients
|
Gal(a1-4)Gal
|
Binding
|
||
Verotoxin (1; B-subunit)
|
CD77 (Globotriaosylceramide; Gb3)
|
Oligoglycosylceramides
|
Germinal center B lymphocytes, Burkitt's lymphoma cells
|
Gal(a1-4)Gal
|
Binding
|
||
Unknown
|
CD77 (Globotriaosylceramide; Gb3)
|
Oligoglycosylceramides
|
Germinal center B lymphocytes, Burkitt's lymphoma cells
|
Gal(a1-4)Gal
|
Binding
|
||
PO
|
unnamed ligand
|
Oligosaccharides
|
human erythrocytes
|
Gal(a1-4)Gal
|
Binding
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01